Log in

2161 JBM (Healthcare) Ltd. HKEX · Hong Kong

JBM (Healthcare) (2161) news

JBM (Healthcare) Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 2161, recorded under Hong Kong. The directory classifies it as Pharmaceuticals: Generic. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest JBM (Healthcare) news

We have not published a story on JBM (Healthcare) yet. When there is news, it will appear here.

Questions about JBM (Healthcare)

What is the ticker symbol of JBM (Healthcare)?

JBM (Healthcare) Ltd. trades under the ticker 2161 on HKEX.

Where is JBM (Healthcare) listed?

JBM (Healthcare) Ltd. is listed on HKEX.

Which country or territory is JBM (Healthcare) listed under?

Our directory records JBM (Healthcare) Ltd. under Hong Kong.

What does JBM (Healthcare) do?

Our directory classifies JBM (Healthcare) Ltd. as: Pharmaceuticals: Generic. This is a directory classification, not a description of the pipeline.

What is the ISIN of JBM (Healthcare)?

The ISIN recorded for JBM (Healthcare) Ltd. is KYG1090B1077.

Does aibio.space cover JBM (Healthcare)?

aibio.space lists JBM (Healthcare) Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to JBM (Healthcare)?

Companies in our directory listed in the same country and business area as JBM (Healthcare): Jacobson Pharma Corporation, Beijing Tong Ren Tang Chinese Medicine Co., Genscript Biotech, SinoMab Bioscience, China Traditional Chinese Medicine Holdings Co., Grand Pharmaceutical Group.

Investor discussion: JBM (Healthcare)

Members talk about JBM (Healthcare) (2161). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at JBM (Healthcare), newest first. Each line links the filing it comes from.

  1. Mergers

    Transaction under the Listing Rules: PROPOSED SPIN-OFF AND SEPARATE LISTING OF JPJ (TCM) LIMITED ON THE MAIN BOARD OF THE STOCK EXCHANGE OF HONG KONG LIMITED. Source

  2. Financings

    Share or debt issue: (1) PROPOSED RE-ELECTION OF DIRECTORS AND (2) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES AND SELL TREASURY SHARES AND (3) PROPOSED RE-APPOINTMENT OF AUDITOR AND (4) NOTICE OF ANNUAL GENERAL MEETING. Source

  3. Financings

    Share or debt issue: (1) PROPOSED RE-ELECTION OF DIRECTORS AND (2) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES AND SELL TREASURY SHARES AND (3) NOTICE OF ANNUAL GENERAL MEETING. Source

  4. Mergers

    Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION ACQUISITION OF TARGET GROUP. Source

  5. Mergers

    Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION COMPLETION OF THE ACQUISITION OF TARGET COMPANY. Source

  6. Mergers

    Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION ACQUISITION OF TARGET COMPANY. Source

Press releases

Headlines of JBM (Healthcare)'s own announcements, newest first. Each opens the full release on the newswire that carried it.

  1. HKEXnews

    (1) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MONDAY, 10 AUGUST 2026; (2) PAYMENT OF FINAL DIVIDEND; AND (3) CHANGE IN COMPOSITION OF BOARD COMMITTEES

  2. HKEXnews

    PROPOSED SPIN-OFF AND SEPARATE LISTING OF JPJ (TCM) LIMITED ON THE MAIN BOARD OF THE STOCK EXCHANGE OF HONG KONG LIMITED

  3. HKEXnews

    Notification Letter and Request Form to Non-registered Shareholders

  4. HKEXnews

    Notification Letter and Reply Form to Registered Shareholders

  5. HKEXnews

    NOTICE OF ANNUAL GENERAL MEETING

  6. HKEXnews

    (1) PROPOSED RE-ELECTION OF DIRECTORS AND (2) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES AND SELL TREASURY SHARES AND (3) PROPOSED RE-APPOINTMENT OF AUDITOR AND (4) NOTICE OF ANNUAL GENERAL MEETING

  7. HKEXnews

    JOINT ANNOUNCEMENT CONNECTED TRANSACTION IN RELATION TO SALE AND PURCHASE OF SHARES IN LI CHUNG SHING TONG (HOLDINGS) LIMITED

  8. HKEXnews

    Final Dividend for the Year Ended 31 March 2026

  9. HKEXnews

    ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 MARCH 2026

  10. HKEXnews

    RETIREMENT OF NON-EXECUTIVE DIRECTOR

  11. HKEXnews

    JOINT ANNOUNCEMENT RENEWAL OF CONTINUING CONNECTED TRANSACTIONS

  12. HKEXnews

    CHANGE OF CHIEF EXECUTIVE OFFICER

  13. HKEXnews

    Interim Dividend for the six months ended 30 September 2025

  14. HKEXnews

    INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025

  15. HKEXnews

    JOINT ANNOUNCEMENT CONNECTED TRANSACTION AND CONTINUING CONNECTED TRANSACTION 2025 EUROPHARM LICENSE AGREEMENT

  16. HKEXnews

    APPOINTMENT OF NON-EXECUTIVE DIRECTOR

  17. HKEXnews

    POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MONDAY, 28 JULY 2025 AND CHANGE IN COMPOSITION OF NOMINATION COMMITTEE

  18. HKEXnews

    Terms of Reference for Nomination Committee

  19. HKEXnews

    RECORD DATE FOR ANNUAL GENERAL MEETING AND PROPOSED FINAL DIVIDEND

  20. HKEXnews

    RESIGNATION OF EXECUTIVE DIRECTOR AND CHANGE OF AUTHORISED REPRESENTATIVE

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:2161 on TradingView.

Listing details

JBM (Healthcare) Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 2161, recorded under Hong Kong. The directory classifies it as Pharmaceuticals: Generic. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
JBM (Healthcare) Ltd.
Ticker
2161
Listing
HKEX
Country or territory
Hong Kong
Business scope
Pharmaceuticals: Generic
ISIN
KYG1090B1077
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.